A Review paper authored by Marco Riboldi

A Review paper authored by Marco Riboldi (CartCas-Lab), Roberto Orecchia (Division of Radiotherapy, IEO) and Guido Baroni (CartCas-Lab) titled “Real-time tumour tracking in particle therapy: technological developments and future perspectives” has been published on the prestigious scientific journal Lancet Oncology. With an impact factor of 22.59, the Lancet Oncology ranks fourth out of 194 oncology journals worldwide, is the leading clinical research journal in oncology, and is in the top 0.5% of all scientific journals, of any discipline, globally (2011 Journal Citation Reports®, ©Thomson Reuters 2012). Download from the journal webpage.